Next Article in Journal
Cell-Penetrating Peptides: A Comparative Study on Lipid Affinity and Cargo Delivery Properties
Next Article in Special Issue
Role of Leukotrienes and Leukotriene Modifiers in Asthma
Previous Article in Journal
Antiproliferative Properties of Type I and Type II Interferon
Previous Article in Special Issue
Article Menu

Export Article

Open AccessReview
Pharmaceuticals 2010, 3(4), 1016-1044; doi:10.3390/ph3041016

Beta-Adrenergic Agonists

Preventive and Occupational Medicine Unit, Respiratory Pathophysiology Laboratory, University Hospital San Martino, Largo R. Benzi, 10 - 16132 Genoa, Italy
Respiratory Pathophysiology Unit, Department of Internal Medicine, University of Genoa, Viale Benedetto XV - 16132 Genoa, Italy
Author to whom correspondence should be addressed.
Received: 2 February 2010 / Revised: 15 March 2010 / Accepted: 26 March 2010 / Published: 30 March 2010
(This article belongs to the Special Issue Antiasthmatic Drugs)
View Full-Text   |   Download PDF [1162 KB, uploaded 30 March 2010]   |  


Inhaled β2-adrenoceptor (β2-AR) agonists are considered essential bronchodilator drugs in the treatment of bronchial asthma, both as symptoms-relievers and, in combination with inhaled corticosteroids, as disease-controllers. In this article, we first review the basic mechanisms by which the β2-adrenergic system contributes to the control of airway smooth muscle tone. Then, we go on describing the structural characteristics of β2-AR and the molecular basis of G-protein-coupled receptor signaling and mechanisms of its desensitization/ dysfunction. In particular, phosphorylation mediated by protein kinase A and β-adrenergic receptor kinase are examined in detail. Finally, we discuss the pivotal role of inhaled β2-AR agonists in the treatment of asthma and the concerns about their safety that have been recently raised.
Keywords: β2-adrenoceptors; G-protein-coupled receptor signaling;airway smooth muscle; bronchodilation; desensitization; safety issues β2-adrenoceptors; G-protein-coupled receptor signaling;airway smooth muscle; bronchodilation; desensitization; safety issues
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Barisione, G.; Baroffio, M.; Crimi, E.; Brusasco, V. Beta-Adrenergic Agonists. Pharmaceuticals 2010, 3, 1016-1044.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top